Technical Analysis for TRVN - Trevena, Inc.

Grade Last Price % Change Price Change
grade D 0.9994 0.95% 0.01
TRVN closed up 0.95 percent on Wednesday, September 18, 2019, on approximately normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Earnings due: Sep 27

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Up Up
See historical TRVN trend table...

Date Alert Name Type % Chg
NR7 Range Contraction 0.00%
NR7-2 Range Contraction 0.00%
Upper Bollinger Band Walk Strength 0.00%
Upper Bollinger Band Touch Strength 0.00%
NR7 Range Contraction 0.95%
Upper Bollinger Band Walk Strength 0.95%
Inside Day Range Contraction 0.95%
Upper Bollinger Band Touch Strength 0.95%
50 DMA Support Bullish 0.34%
Expansion Pivot Buy Setup Bullish Swing Setup 0.34%

Older signals for TRVN ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Trevena, Inc., a clinical stage biopharmaceutical company, focuses on discovering and developing therapeutics for G protein coupled receptors. Its products include TRV027 that has completed Phase 2a clinical trials for the treatment of acute heart failure; TRV130, a small molecule G protein biased ligand at the µ-opioid receptor has completed Phase 1b clinical trials to treat moderate to severe acute pain intravenously; TRV734 that is in preclinical studies as a orally administered treatment of moderate to severe acute and chronic pain; and d-opioid receptor G protein biased ligand therapeutics for the treatment of central nervous system disorders. The company was formerly known as Parallax Therapeutics, Inc. and changed its name to Trevena, Inc. in January 2008. Trevena, Inc. was founded in 2007 and is based in King of Prussia, Pennsylvania.
Pain Organic Compounds Central Nervous System Disorders Analgesics Cell Signaling Pyridines Signal Transduction Treatment Of Central Nervous System Disorders Opioid Acute Heart Failure Thiophenes
Is TRVN a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 3.58
52 Week Low 0.38
Average Volume 544,628
200-Day Moving Average 1.0992
50-Day Moving Average 0.927
20-Day Moving Average 0.8971
10-Day Moving Average 0.9444
Average True Range 0.0741
ADX 21.34
+DI 26.4428
-DI 13.7232
Chandelier Exit (Long, 3 ATRs ) 0.8477
Chandelier Exit (Short, 3 ATRs ) 0.9024
Upper Bollinger Band 1.0258
Lower Bollinger Band 0.7684
Percent B (%b) 0.9
BandWidth 28.692454
MACD Line 0.0181
MACD Signal Line -0.0005
MACD Histogram 0.0185
Fundamentals Value
Market Cap 59.66 Million
Num Shares 59.7 Million
EPS -1.94
Price-to-Earnings (P/E) Ratio -0.52
Price-to-Sales 0.00
Price-to-Book 1.66
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.07
Resistance 3 (R3) 1.08 1.06 1.06
Resistance 2 (R2) 1.06 1.04 1.06 1.06
Resistance 1 (R1) 1.03 1.03 1.02 1.02 1.05
Pivot Point 1.01 1.01 1.00 1.01 1.01
Support 1 (S1) 0.98 0.99 0.97 0.97 0.95
Support 2 (S2) 0.96 0.98 0.96 0.94
Support 3 (S3) 0.93 0.96 0.94
Support 4 (S4) 0.92